BAY 1125976, a selective allosteric AKT1/2 inhibitor, exhibits high efficacy on AKT signaling-dependent tumor growth in mouse models.
Int J Cancer
; 140(2): 449-459, 2017 Jan 15.
Article
in En
| MEDLINE
| ID: mdl-27699769
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sulfones
/
Signal Transduction
/
Protein Kinase Inhibitors
/
Proto-Oncogene Proteins c-akt
/
Nitriles
Type of study:
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
/
Male
Language:
En
Journal:
Int J Cancer
Year:
2017
Document type:
Article
Affiliation country:
Alemania